Market Tracker

01/18 8:47am ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

33.75
Delayed Data
As of Jan 17
 -0.22 / -0.65%
Today’s Change
33.56
Today|||52-Week Range
64.31
-6.90%
Year-to-Date
Rhenman & Partners Asset Management AB Buys Gilead Sciences Inc, Medtronic PLC, Pfize...
Jan 13 / GuruFocus News - Paid Partner Content
Teva May Have Found a Cure for Last Year
Jan 11 / TheStreet.com - Paid Partner Content
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
Jan 13 / Zacks.com - Paid Partner Content
Merrimack (MACK) Sells Onivyde Rights to Ipsen for $1B
Jan 09 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
3 Top Dividend Stocks Selling for a Discount This Winter
Jan 09 / MotleyFool.com - Paid Partner Content
Patent Victory Secures Lilly Hold on Cancer Drug Until 2022
Jan 12 / TheStreet.com - Paid Partner Content
Stock Market News for January 09, 2017
Jan 09 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for January 11th
Jan 11 / Zacks.com - Paid Partner Content
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close33.97
Today’s open34.05
Day’s range33.62 - 34.12
Volume9,978,935
Average volume (3 months)9,120,003
Market cap$34.2B
Dividend yield4.03%
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-5.36%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-3.22%
P/E ratio19.5
Price/Sales2.89
Price/Book1.16

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.20+0.61%
OASMOasmia Pharmaceutica...+0.81+28.23%
Data as of 01/17/2017

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$1.36
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts